The short answer
A vulvar biopsy is a procedure in which a small sample of vulvar tissue is removed and sent for microscopic laboratory examination. It may be considered when examination, swabs, blood tests, or the response to prior treatment do not fully explain a visible or persistent vulvar problem. 1 3 4
A recommendation for biopsy does not mean “you have cancer.” Biopsy is a way to reduce diagnostic uncertainty across inflammatory, precancerous, malignant, and other skin conditions. 1 2 3
Why inspection is sometimes not enough
Vulvar conditions can overlap in color, texture, ulceration, thickening, thinning, and symptoms. ACOG notes that biopsy is sometimes needed to confirm a vulvar disease. 1 Its VIN guidance gives examples where biopsy is appropriate, including lesions that cannot be definitively diagnosed clinically, possible malignancy, failure of a presumed diagnosis to respond to usual therapy, atypical vascular patterns, or rapid changes in a stable lesion. 2
Those are examples of diagnostic uncertainty, not a checklist for self-selecting a biopsy from home.
For the broader visible-change route, see vulvar color or texture changes with itching.
Consent comes before the procedure
Cambridge University Hospitals states that consent is obtained before biopsy and that patients have an opportunity to ask questions or request more information. 4 A 2026 Worcestershire NHS leaflet also states that a patient can say no to the procedure, while explaining that diagnosis may take longer without the sample. 5
Consent is part of the decision, not a formality after it.
What usually happens
Current NHS patient information describes local anaesthetic being injected into the vulvar skin before a small tissue sample is removed. 3 4 The anaesthetic injection can sting briefly, and the site may feel tender as it heals. 4 This is why “local anaesthetic” should not be translated into a promise that the whole experience is pain-free.
Depending on the size and site, a stitch or another method may be used to control bleeding and close the biopsy site. 4 The exact technique is decided locally.
Risks and limits
CUH lists a small scar, bleeding, and infection among recognized risks. 4 The Worcestershire leaflet likewise describes uncommon bleeding, infection, haematoma, and a small scar. 5
Importantly, the same 2026 leaflet notes that sometimes it is not possible to make a diagnosis from the sample. 5 A biopsy can be highly informative without being a guaranteed definitive answer.
Pathology still needs clinical interpretation
A pathology report answers what the sampled tissue shows. It does not automatically explain every symptom outside the sampled site, and it needs to be interpreted with the appearance, history, other tests, and the reason the sample was taken.
If fissures or cracks are the main finding, see vulvar fissures, cracks, and itching. If lichen sclerosus is the specific question, see vulvar lichen sclerosus and itching.
Bottom line
Vulvar biopsy is a diagnostic tool for uncertainty, not a cancer verdict and not a procedure a reader should self-order from a web checklist. Its purpose, alternatives, local anaesthetic, risks, consent, and possibility of a nondiagnostic result should all remain visible before treating pathology as the next step.
Medical-information boundary
This article provides general health information and does not diagnose an individual or select a patient-specific treatment. See the medical information disclaimer.
Sources
- ACOG: Disorders of the Vulva. Evidence reviewed 2026-09-14. Biopsy may be needed in some cases to confirm the diagnosis of vulvar disease.
- ACOG: Management of Vulvar Intraepithelial Neoplasia. Evidence reviewed 2026-09-14. Selected visible-lesion biopsy indications and histopathology role.
- Kingston and Richmond NHS: Vulval biopsy. Evidence reviewed 2026-09-14. Updated 2026 description of biopsy purpose and local-anaesthetic procedure.
- Cambridge University Hospitals: Vulval biopsy. Evidence reviewed 2026-09-14. Consent, opportunity for questions, local anaesthetic, bleeding/infection/scar risks, and result follow-up.
- Worcestershire Acute Hospitals: Vulval or vaginal biopsy. Evidence reviewed 2026-09-14. 2026 leaflet covering right to decline, risks, and possibility that a sample may not yield a diagnosis.